Genetic variation in heroin-induced changes in behaviour: Effects of B6 strain dose on conditioned reward and locomotor sensitization in 129-B6 hybrid mice

Genes, Brain and Behavior

Volumn 4, Issue 5, 2005, Pages 324-336

  Szumlinski, K K ^a   Lominac, K D ^a   Frys, K A ^a   Middaugh, L D ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MUSC Center for Drug and Alcohol Programs   (United States)

Author keywords

Heroin; Locomotor sensitization; Mice; Place conditioning; Strain differences; Strain dose; Transgenics

Indexed keywords

DIAMORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; GENETIC VARIABILITY; HYBRID; LOCOMOTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSGENIC ANIMAL;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); ENVIRONMENT; FEMALE; GENE DOSAGE; GENETICS, BEHAVIORAL; HEROIN; HYBRIDIZATION, GENETIC; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; REINFORCEMENT (PSYCHOLOGY); SPECIES SPECIFICITY;

ANIMALIA;

EID: 22344439493     PISSN: 16011848     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2004.00111.x     Document Type: Article

References (100)

1. Alexander, R.C., Heydt, D., Ferraro, T.N., Vogel, W. & Berrettini, W.H. (1996) Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice. Psychiatr Genet 6, 29-31.
2. Babbini, M. & Davis, W.H. (1972) Time-dose relationship for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 46, 213-224.
3. Balough, S.A., McDowell, C.S., Stavnezer, A.J. & Denenberg, V.H. (1999) A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL/6 mice. Brain Res 836, 38-48.
4. Baran, A., Shuster, L., Elefheriou, B.E. & Bailey, D.W. (1975) Opiate receptors in mice: genetic differences. Life Sci 17, 633-640.
5. Bardo, MT. & Bevins, B.A. (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153, 31-43.
6. Bartoletti, M., Gaiardi, M., Gubellini, C., Bacchi, A. & Babbini, M. (1987) Previous treatment with morphine and sensitization to the excitatory actions of opiates: dose-effect relationship. Neuropharmacology 26, 115-119.
7. Becker, A., Grecksch, G., Brodemann, R., Kraus, J., Peters, B., Schroeder, H., Thiemann, W., Loh, H.H. & Hollt, V. (2000) Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 361, 584-589.
8. Belknap, J.K. (1990) Physical dependence induced by the voluntary consumption of morphine in inbred mice. Pharmacol Biochem Behav 35, 311-315.
9. Belknap, J.K., Crabbe, J.C., Riggan, J. & O'Toole, L.A. (1993) Voluntary consumption of morphine in 15 inbred strains. Psychopharmacology 112, 352-358.
10. Belknap, J.K., Lame, M. & Danielson, P.W. (1990) Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment. Behav Genet 20, 333-338.
11. Belzung, C., Misslin, R., Vogel, E., Dodd, R.H. & Chapouthier, G. (1987) Anxiogenic effects of methyl-β-carboline-carboxylate in a light/dark choice situation. Pharmacol Biochem Behav 28, 29-33.
12. Berrettini, W.H., Alexander, R., Ferraro, T.N. & Vogel, W.H. (1994a) A study of oral morphine preference in inbred mouse strains. Psychiatr Genet 4, 81-86.
13. Berrettini, W.H., Ferraro, T.N., Alexander, B.C., Buchberg, A.M. & Vogel, W.H. (1994b) Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet 7, 54-58.
14. Berrettini, W.H., Hoehe, M.R., Ferrada, T.N. & Gottheil, C. (1997) Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 2, 303-308.
15. Bohn, L.M., Gainetdinov, R.R., Sotnikova, T.D., Medvedev, I.O., Lefkowitz, R.J., Dykstra, L.A. & Caron, M.C. (2003) Enhanced rewarding properties of morphine, but not cocaine, in βarrestin-2 knock-out mice. J Neurosci 23, 10265-10273.
16. Bond, C., LaForge, K.S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J.A., Leal, S.M., Tischfield, J.A., Kreek, M.J. & Yu, L. (1998) Single-nucleotide polymorphism in the human mu opioid receptor genes alters beta-endophorin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95, 9608-9613.
17. Brase, D.A., Loh, H.H. & Way, E.L. (1977) Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201, 368-374.
18. Cadoret, R.J., Troughton, E., O'Gorman, T.W. & Heywood, E. (1986) An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 43, 1131-1136.
19. Carr, G.D., Fibiger, H.C. & Phillips, A.G. (1989) Conditioned place preference as a measure of drug reward. In Liebman, J.M. & Cooper, S.J. (eds), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264-319.
20. Castellano, C. & Oliverio, A. (1975) A genetic analysis of morphine-induced running and analgesia in the mouse. Psychopharmacologia 41, 197-2000.
21. Crabbe, J.C., Phillips, T.J., Buck, K.J., Cunningham, C.L. & Belknap, J.K. (1999) Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci 22, 173-179.
22. Crawley, J.N. & Davis, L.G. (1982) Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 8, 609-612.
23. Crawley, J.N., Belknap, J.K., Collins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A. & Paylor, R. (1997) Behavioral phenotypes of inbred mouse strains: recommendations for molecular studies. Psychopharmacology 132, 107-124.
24. Crowley, J.J., Oslin, D.W., Patkar, A.A., Gottheil, E., DeMaria, P.A. Jr, O'Brien, C.P., Berrettini, W.H. & Grice, D.E. (2003) A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 13, 169-173.
25. Cunningham, C.L., Niehus, D.R., Malott, D.H. & Prather, L.K. (1992) Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology 107, 385-393.
26. Dockstader, C.L. & van der Kooy, D. (2001) Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning. J Neurosci 21, 9077-9081.
27. Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S. & Tassin, J.P. (2002) Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22, 2873-2884.
28. Elmer, G.I., Pieper, J.O., Rubinstein, M., Low, M.J., Grandy, D.K. & Wise, R.A. (2002) Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 22, RC224.
29. Funada, M., Suzuki, T., Narita, M., Misawa, M. & Nagase, H. (1993) Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32, 1315-1323.
30. Gadd, C.A., Murtra, P., De Felipe, C. & Hunt, S.P. (2003) Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci 10, 8271-8280.
31. Gerlai, R. (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19, 177-181.
32. Gerra, G., Garofano, L., Bosari, S., Pelligrini, C., Zaimovic, A., Moi, G., Bussandri, M., Moi, A., Brambilla, F., Mameli, A., Pizzomiglio, M. & Donnini, C. (2004) Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. J Neural Transm 111, 611-621.
33. Gould, T.J. & Wehner, J.M. (1999) Genetic influences on latent inhibition. Behav Neurosci 113, 1291-1296.
34. Hall, F.S., Li, X.-F., Goeb, M., Roff, S., Hoggatt, H., Sora, I. & Uhl, G.R. (2003) Congenic C57BL/6 μ opiate receptor (MOR) knockout mice: baseline and opiate effects. Genes Brain Behav 2, 114-121.
35. Hand, T.H., Stinus, L. & Le Moal, M. (1989) Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology 98, 61-67.
36. Hoehe, M.R., Kopke, K., Wendel, B., Rohde, K., Flachmeier, C., Kidd, K.K., Berrettini, W.H. & Church, G.M. (2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 9, 2895-2908.
37. Holmes, A., Wrenn, C.C., Harris, A.P., Thayer, K.E. & Crawley, J.N. (2002) Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1, 55-69.
38. Horowitz, G.P., Whitney, G., Smith, J.C. & Stephan, F.K. (1977) Morphine ingestion: genetic control in mice. Psychopharmacology 52, 119-122.
39. Inturrisi, C.E., Schultz, M., Shin, S., Umans, J.G., Angel, L. & Simon, E.J. (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 33, 773-776.
40. Kest, B., Beczkowska, I., Franklin, S.O., Lee, C.E., Mogil, J.S. & Inturrisi, C.E. (1998) Differences in delta opioid receptors antinociception, binding, an mRNA levels between BABL/c and CXBK mice. Brain Res 805, 131-137.
41. Kest, B., Hopkins, E., Palmese, C.A., Adler, M. & Mogil, J.S. (2002) Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. Pharmacol Biochem Behav 73, 821-828.
42. Kieffer, B.L. & Gaveriaux-Ruff, B. (2002) Exploring the opioid system by gene knock-out. Prog Neurobiol 66, 285-306.
43. Kozak, C.A., Filie, J., Adamson, M.C., Chen, Y. & Yu, L. (1994) Murine chromosomal location of the mu and kappa opioid receptor genes. Genomics 21, 659-661.
44. Kuribara, H. & Tadokoro, S. (1989) Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strains. Jpn J Pharmacol 49, 197-203.
45. Lasagna, L., von Felsinger, J.M. & Beecher, H.K. (1955) Drug-induced mood changes in man. 1. Observations on healthy subjects, chronically ill patients, and "postaddicts". JAMA 157, 1006-1020.
46. Logue, S.F., Owen, E.H., Rasmussen, D.L. & Wehner, J.M. (1997) Assessment of locomotor activity, acoustic startle and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 80, 1075-1086.
47. Maddux, J.F. & Desmond, D.P. (1984) Heroin addicts and non-addicted brothers. Am J Drug Alcohol Abuse 10, 237-248.
48. Maldonado, R., Saiardi, A., Valverde, O., Samad, T.A., Roques, B.P. & Borrelli, E. (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586-589.
49. Mather, L.E. (1987) Opioid pharmacokinetics in relation to their effects. Anaesth Intensive Care 15, 15-22.
50. Matthes, H.W., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., Tzavara, E., Hanoune, J., Roques, B.P. & Kieffer, B.L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823.
51. McNamee, H.B., Mirin, S.M., Kuehnle, J.C. & Meyer, R.E. (1976) Affective changes in chronic opiate use. Br J Addict Alcohol Other Drugs 71, 275-280.
52. Melton, D.W. (1994) Gene targeting in the mouse. Bioessays 16, 633-639.
53. Merikangas, K.R., Stolar, M., Stevens, D.E., Goulet, J., Preisig, M.A., Fenton, B., Zhang, H., O'Malley, S.S. & Rounsaville, B.J. (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55, 973-979.
54. Middaugh, L.D. & Zemp, J.W. (1976) Effects of methadone on activity and on brain monoamines in two strains of mice. Pharmacol Biochem Behav 5, 367-370.
55. Miner, L.L. (1997) Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol Biochem Behav 58, 25-30.
56. Mirin, S.M., Meyer, R.C. & McNamee, H.B. (1976) Psychopathology and mood during heroin use. Arch Gen Psychiatry 33, 1503-1508.
57. Mogil, J., Sternberg, W., Marek, P., Sadowski, B., Belknap, J. & Liebeskind, J. (1996) The genetics of pain and pain inhibition. Proc Natl Acad Sci USA 93, 3048-3055.
58. Mori, T., Nomura, M., Nagase, H., Narita, M. & Suzuki, T. (2002) Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacology 161, 17-22.
59. Moskowitz, A.S., Terman, G.W., Carter, K.R., Morgan, M.J. & Liebeskind, J.C. (1985) Analgesic, locomotor and lethal effects of morphine in the mouse: strain comparisons. Brain Res 361, 46-51.
60. Murphy, N.P., Lam, H.A. & Maidment, N.T. (2001) A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem 79, 626-635.
61. Nader, K., Bechara, A., Roberts, D.C. & van der Kooy, D. (1994) Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation. Behav Neurosci 108, 1128-1138.
62. Narita, M., Mizou, K., Mizoguchi, H., Sakata, M., Narita, M., Tseng, L.F. & Suzuki, T. (2003) Molecular evidence for the functional role of dopamine D3 receptor in morphine-induced rewarding effect and hyperlocomotion. J Neurosci 23, 1006-1012.
63. Oliverio, A. & Castellano, C. (1974) Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia 39, 13-22.
64. 1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 80, 1087-1099.
65. Paylor, R. & Crawley, J.N. (1997) Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132, 169-180.
66. Petruzzi, R., Ferraro, T.N., Kurschner, V.C., Golden, G.T. & Berrettini, W.H. (1997) The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6 and DBA/2J mice. Life Sci 61, 2057-2064.
67. Pickens, R.W., Preston, K.L., Miles, D.R., Gupman, A.E., Johnson, E.O., Newlin, D.B., Soriano, J., van den Bree, M.B.M. & Umbricht, A. (2001) Family history influence on drug abuse severity and treatment outcome. Drug Alcohol Depend 6, 261-270.
68. Rady, J.J., Elmer, G.I. & Fujimoto, J.M. (1999) Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice. J Pharmacol Exp Ther 288, 438-445.
69. Robson, L.E., Gillan, M.G. & Kosterlitz, H.W. (1985) Species differences in the concentrations and distributions of opioid binding sites. Eur J Pharmacol 112, 65-71.
70. Sante, A.B., Nobre, M.J. & Brandao, M.L. (2000) Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11, 583-589.
71. Semenova, S., Kuzmin, A. & Zvartau, E. (1995) Strain differences in the analgesic and reinforcing action of morphine in mice. Pharmacol Biochem Behav 50, 17-21.
72. Shi, J., Hui, L., Xu, Y., Wang, F., Huang, W. & Hu, G. (2002) Sequence variation in the mu-opioid receptor gene (ORPM1) associated with human addiction to heroin. Hum Mutat 19, 459-460.
73. Shimosato, K. & Ohkuma, S. (2000) Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and amphetamine. Pharmacol Biochem Behav 66, 285-292.
74. Shin, D.M., Dehoff, M., Luo, X., Kang, S.H., Tu, J., Nayak, S.K., Ross, E.M., Worley, P.F. & Muallem, S. (2003) Homer 2 tunes G protein-coupled receptors stimulus intensity by regulating RGS proteins and PLCbeta GAP activities. J Cell Biol 162, 293-303.
75. Shippenberg, T.S. & Herz, A. (1986) Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res Monogr 75, 563-566.
76. Shuster, L., Webster, G.W. & Eleftheriou, B.E. (1975) A genetic analysis of the running response to morphine in mice. Psychopharmacologia 42, 249-254.
77. Silva, A.J., Simpson, E.M., Takahashi, J.S., Lipp, H.-P., Nakanishi, S., Whener, J.M., Giese, K.P., Tully, T., Abel, T., Chapman, P.F., Fox, K., Grant, S., Itohara, S., Lathe, R., Mayford, M., McNamara, J.O., Morris, R.J., Piciotto, M., Roder, J., Shin, H.-S., Slesinger, P.A., Storm, D.R., Stryker, M.P., Tonegawa, S., Want, Y. & Wolfer, D.P. (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on Genetic Background in Mice. Neuron 19, 755-769.
78. Sora, I., Elmer, G., Funada, M., Pieper, J., Li, X.F., Hall, F.S. & Uhl, G.R. (2001) Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 25, 41-54.
79. Spanagel, R., Almeida, O.F., Bartl, C. & Shippenberg, T.S. (1994) Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115, 121-127.
80. Suzuki, T., Shiozaki, Y., Masukawa, Y., Misawa, M. & Nagase, H. (1992) The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58, 435-442.
81. Szumlinski, K.K., Maisonneuve, I.M. & Glick, S.D. (2000) The potential anti-addictive agent, 18-methoxycoronaridine (18-MC), blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment. Brain Res 864, 13-23.
82. Szumlinski, K.K., Price, K.L., Frys, KA & Middaugh, L.D. (2002) Unconditioned and conditioned factors contribute to the " reinstatement" of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res 136, 151-160.
83. Szumlinski, K.K., Toda, S., Middaugh, L.D., Worley, P.F. & Kalivas, P.W. (2003) Evidence for a relationship between Group 1 mGluR hypfunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice. Ann NY Acad Sci 1003, 468-471.
84. Szumlinski, K.K., Dehoff, M.H., Kang, S.H., Frys, K.A., Lominac, K.D., Rohrer, J., Griffin, W. III, Klugmann, M., Toda, S., Champtiaux, N.P., Berry, T., Shealy, S., Tu, U.C., During, M.T., Middaugh, L.D., Worley, P.F. & Kalivas, P.W. (2004) Homer proteins regulate sensitivity to cocaine. Neuron 43, 401-413.
85. Tschacher, W., Haemming, R. & Jacobshagen, N. (2003) Time series modeling of heroin and morphine drug action. Psychopharmacology 165, 188-193.
86. Tsuang, M.T., Lyons, M.J., Eisen, SA, Goldberg, J., True, W., Lin, N., Meyer, J.M., Toomey, R., Faraone, S.V. & Eaves, L. (1996) Genetic influences on DSM-III-R drug abuse and dependence: a study of 3372 twin pairs. Am J Med Genet 67, 473-477.
87. Tsuang, M.T., Lyons, M.J., Meyer, J.M., Doyle, T., Eisen, S.A., Goldberg, J., True, W., Lin, N., Toomey, R. & Eaves, L. (1998) Co-occurance of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55, 967-972.
88. Tsuang, M.T., Lyons, M.J., Harley, R.M., Xian, H., Eisen, S., Goldberg, J., True, W.R. & Faraone, S.V. (1999) Genetic and environmental influences on transitions in drug use. Behav Genet 29, 473-479.
89. Uhl, G.R., Sora, I. & Wang, Z. (1999) The mu opiate receptor as a candidate for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA 96, 7752-7755.
90. Vaught, J.L., Mathiasen, J.R. & Raffa, R.B. (1988) Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. J Pharmacol Exp Ther 245, 13-16.
91. Voikar, V., Koks, S., Vasar, E. & Rauvala, H. (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72, 271-281.
92. Voikar, V., Vasar, E. & Rauvala, H. (2004) Behavioral alterations induced by repeated testing in C57BL/6 and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav 3, 27-38.
93. de Waele, J.P. & Gianoulakis, C. (1997) Characterization of the mu and delta opioid receptors in the brain of the C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. Alcohol Clin Exp Res 21, 754-762.
94. Wahlsten, D., Metten, P., Phillips, T.J., Boehm, S.L. III, Burkhart-Kasch, S., Dorow, J., Doerksen, S., Downing, C., Fogarty, J., Rodd-Henricks, K., Hen, R., McKinnon, C.S., Merrill, C.M., Nolte, C., Schalomon, M., Schulmbohm, J.P., Sibert, J.R., Wenger, C.D., Dudek, B.C. & Crabbe, J.C. (2003) Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 54, 283-311.
95. Way, E.L., Kemp, J.W., Young, J.M. & Grassetti, D.R. (1960) The pharmacologic effects of heroin in relationship to its rate of biotransformation. J Pharmacol Exp Ther 129, 144-154.
96. Way, E.L., Young, J.M. & Kemp, J.W. (1965) Metabolism of heroin and its pharmacologic implications. Bull Narc 17, 25-33.
97. Winkler, A. & Spanagel, R. (1998) Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains. Neuroreport 11, 1459-1464.
98. Xu, K., Litcherman, D., Lipsky, R.H., Franke, P., Liu, X., Hu, Y., Cao, L., Schwab, S.G., Wildenauer, D.B., Bau, C.H., Ferro, E., Astor, W., Finch, T., Terry, J., Taubman, J., Maier, W. & Goldman, D. (2004) Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 61, 597-606.
99. Yu, L. (1996) The mu opioid receptor: from molecular cloning to functional studies. Addict Biol 1, 19-30.
100. Zhou, L., Rowley, D.L., Mi, Q.S., Sefcovic, N., Matthes, H.W., Kieffer, B.L. & Donovan, D.M. (2001) Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells. Mamm Genome 12, 772-778.